Activist Shareholder BBRC Intensifies Proxy Fight Against Board Chair Donna James
VSCO has more than doubled off its 52-week low of $17.53.
Summary
Activist shareholder BBRC International, holding a 13% stake, has released new materials to intensify its campaign against Victoria's Secret Board Chair Donna James, urging shareholders to vote against her re-election at the upcoming annual meeting.
Key Events · Ownership and Investor Activity · VSCO
-
Proxy Contest Escalation
BBRC International, a 13% shareholder, released a new investor presentation and launched a dedicated website to intensify its campaign against Board Chair Donna James.
-
Call for Board Chair Removal
The activist investor is urging stockholders to vote AGAINST the re-election of Donna James at the June 11 annual meeting, citing her 25-year tenure and alleged value-destructive decisions.
-
Detailed Criticisms of Leadership
BBRC highlights sustained underperformance, declining stockholder support, poor oversight of the Wexner-Epstein ties, the failed Adore Me acquisition (with $155.9 million in impairments), and ineffective buybacks as reasons for change.
-
Focus on Turnaround Protection
BBRC believes a new Board Chair with operating experience is crucial to protect and accelerate the company's turnaround efforts under CEO Hillary Super.
Analysis · VSCO · Trade & Services
BBRC International, Victoria's Secret's second-largest shareholder with a 13% stake, is escalating its proxy contest against Board Chair Donna James. This filing includes a new investor presentation and website launch, detailing a strong case for her removal ahead of the June 11 annual meeting. The accusations of value-destructive decisions, including the failed Adore Me acquisition and sustained underperformance, represent a significant challenge to the company's current leadership and could lead to a change in board composition.
At the time of this filing, VSCO was trading at $45.00 on NYSE in the Trade & Services sector, with a market capitalization of approximately $3.6B. The 52-week trading range was $17.53 to $66.89. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.